share_log
Reuters ·  Mar 10 20:14

Mar 10 (Reuters) - Coherus BioSciences Q4 Pretax Profit USD -50.696 Million Vs. IBES Estimate USD -20.6 Million.

  • Q4 Sales USD 53.933 Million Vs. IBES Estimate USD 47.3 Million
  • Q4 Operating Income USD -42.246 Million Vs. IBES Estimate USD -30.1 Million
  • Q4 Adjusted Net Income USD -32.5 Million Vs. IBES Estimate USD -14.4 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Write a comment